Benefit where it is needed – professionalism where it is possible

Professional use for acute and chronic pain!

Experience in microcurrent therapy since the 2000 Sydney Olympics.

20 years of microcurrent – research, development and production

Experience microcurrent therapy online!

Over 19 hours of online training, user forum, ebooks and much more! Simply register for free!

Luxxamed Microcurrent Podcast the latest episode

3 facts about frequency-specific microcurrent from Luxxamed

Areas of application

  • Acute pain
  • Chronic pain
  • Neurological complaints

(Proven intended purpose according to RL 93/42/EEC Annex X (MEDDEV 2.7/1 rev. 04), MPG § 3)

Advantages for your practice

  • Easy to use
  • Fully delegable
  • Self-regulating therapy system

Control via the Apple iPad pro enables intuitive operation.

Quality for your use

  • CE-marked medical device CE0044 (Annex II, Directive 93/42/EEC)
  • Biologically evaluated (DIN EN ISO 10993-1)
  • Clinically evaluated (Annex X, Directive 93/42/EEC)

Therapy with the Luxxamed - help for your pain patients

Persistent pain – such as that caused by osteoarthritis – impairs your patients' quality of life. We at Luxxamed microcurrent therapy have dedicated ourselves to cybernetic pain therapy, which directly targets the cells.

By influencing energy metabolism and regulating inflammatory processes, the therapy can help in many cases of acute or chronic pain, for example in postoperative applications:

The effect to the point - application rich in your practice

During therapy with Luxxamed frequency-specific microcurrent (FSM), electrical regulation of the tissue takes place with extremely weak, metabolic potentials, so-called microcurrents. These move in the microampere range. The procedure is also known under the abbreviation BCR therapy, which means: Biological Cell Regulation. This method has been successfully used in many practices since the year 2000. The therapy can help to improve the energy metabolism of the tissue. (Cheng, 1982)

A complementary benefit is offered by the use of LED light therapy, which can be applied directly to painful areas such as trigger points, inflammation, etc. (Wetzel & Karutz, 2013)

Luxxamed therapy can be used for various types of pain (Smith, 2001). These can include:

Acute and chronic pain of the joint and musculoskeletal system. (Field of application proven according to RL 93/42/EWG Annex X, MPG § 3) (Rockstroh, 2010)

Pain in the musculature. (Field of application proven according to RL 93/42/EWG Annex X, MPG § 3) (McMakin, 2005)

Individual treatment with Luxxamed

Our innovative devices determine the metabolic state of the tissue before treatment and then automatically decide which therapy parameters to use. The average treatment time is 30 minutes. Even during this time, the device constantly adjusts the parameters of the treatment, which can make the therapy with the Luxxamed so individual and effective.

LED light therapy is also used in your practice. Here, the cell metabolism of the tissue is additionally stimulated by the application of 3 different wavelengths (colors: red-green-blue).

Especially in combination with manual-therapeutic or osteopathic procedures, this is a very positive possibility for the patients in your practice.

Microcurrent therapy and its effectiveness

Today, we know that painful complaints are also caused or promoted by metabolic problems in the cells. Our devices create an individual therapy program with the information revealed by the painful tissue. The gentle energy that stimulates the treated area quickly activates the needed healing and regeneration processes in the therapy. (McMakin, 2005) Likewise, the lymphatic circulation in the body is supported. The reliable removal of the increased waste products of the metabolism supports the self-healing powers of the body. (Cheng, 1982)

The effect on metabolism

The balance of the metabolism in the tissue or in the individual cells is quickly restored. This is how the beneficial pain relief is achieved.

Luxxamed therapy was first used in high-performance sports and has been proven by studies. The devices are approved and CE marked products in the European Union. Luxxamed GmbH is certified according to DIN EN ISO 13485 by TÜV Nord.

If you would like to learn more about Luxxamed and our innovative products and how they can be used for therapy in your practice, please browse through our pages or simply contact us.

Good to know

Continuously tested and certified

Certified quality management system for the manufacture and development of medical devices according to DIN EN ISO 13485:2016

So that as a user always find the right approach! Frequency-specific micro current in the application.

Competence and commitment – Our team of developers, doctors and therapists, so that you are always properly advised!

Latest state of the art developments – Luxxamed LED light therapy researched in collaboration with the Fraunhofer Institute! Discover more of our news!

Luxxamed HD2000+ | Das PLUS macht den Unterschied!

Abgestimmt auf die Bedürfnisse von Ärzten, Physiotherapeuten und Heilpraktikern

Der neue HD2000+ bietet Ihnen Nutzen dort, wo er nötig ist und Professionalität, wo sie möglich ist!

Mobility meets stational stability … After more than 18 months of development, we have succeeded in developing a device tailored to the needs of doctors, physiotherapists and alternative practitioners that complies with the latest laws and guidelines and offers stationary use in the practice and mobile use for home visits or professional sports via the latest web server technology. Through ongoing studies we were able to further improve the well-known and successful therapy of the Luxxamed device family and bring LED light therapy to a completely different level. Evidence of biocompatibility and measurements of light wavelengths as well as intensities helped to determine the correct parameters.


CHENG, N., van HOOF, H., BOCKX, E., HOOGMARTENS, M. J., MULIER, J. C., DIJCKER, F. J. de et al. (1982). The Effects of Electric Currents on ATP Generation, Protein Synthesis, and Membrane Transport in Rat Skin. Clinical Orthopaedics and Related Research, &NA; (171), 264-272.

McMakin, C. R., Gregory, W. M. & Phillips, T. M. (2005). Cytokine changes with microcurrent treatment of fibromyalgia associated with cervical spine trauma. Journal of Bodywork and Movement Therapies, 9 (3), 169–176.

Rockstroh, G., Schleicher, W. & Krummenauer, F. (2010). Der Nutzen der während einer stationären Anschlussheilbehandlung applizierten Mikrostromtherapie bei Patienten nach Implantation einer Knie-Totalendoprothese – eine randomisierte, klinische Studie // Der Nutzen der während einer stationären Anschlussheilbehandlung applizierten Mikrostromtherapie bei Patienten nach Implantation einer Knie-Totalendoprothese – eine randomisierte, klinische Studie. Rehabilitation, 49 (03 // 3), 173–179.

Smith, R. B. (2001). Is Microcurrent Stimulation Effective in Pain Management? An Additional Perspective. American Journal of Pain Management, 11 (1), 64–68.

Wetzel, C., & Karutz, A. (2013, June 3). Ermittlung des Einusses der Nanophotonentechnologie auf invitro Zellkulturen (Master-Thesis). Internationale Hochschule Zittau, Zittau.

The content on this website is directed exclusively to persons who operate the medical devices in the exercise of their commercial, independent professional or freelance activity within the meaning of § 14 BGB. (Doctors, physiotherapists, non-medical practitioners) The information is exclusively for this group of persons and is not intended for consumers within the meaning of § 13 BGB. Consumers or patients please contact your doctor or therapist.

The Luxxamed devices are medical devices in the sense of the MDD 93/42/EWG directive. According to Annex II of the Directive, the conformity assessment procedure for CE marking has been carried out and the devices have been approved in the field of pain therapy (acute and chronic) and neurological complaints in the European Union. The clinical performance and effect for the advertised indications were proven within the framework of the CE marking, in accordance with Annex X of Directive 93/42/EEC (MEDDEV 2.7.1 rev. 04) and tested and approved by TÜV Nord.